Skip to main content
. 2022 Feb 17;197(3):293–301. doi: 10.1111/bjh.18066

TABLE 3.

Relationship between S protein antibody status and T‐cell response in all participants after the second COVID‐19 vaccine dose

Anti‐S status after second vaccine
All participants Myeloma Smouldering myeloma
<50 iu/ml ≥50 iu/ml <50 iu/ml ≥50 iu/ml <50 iu/ml ≥50 iu/ml
T spot n = 12 n = 155 n = 12 n = 146 n = 9
Negative n = 65 10 (15.4%) 55 (84.6%) 10 (16.4%) 51 (83.6%) 4
Positive n = 102 2 (2.0%) 100 (98.0%) 2 (2.1%) 95 (97.4%) 5

n = 167.3 patients had indeterminate T‐spot results whose data not shown. Row percentages shown. Fisher's exact p = 0.001 for all participants and myeloma participants.